Weigold, F. (2018). Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.
Chicago-Zitierstil (17. Ausg.)Weigold, Florian. Antibodies Against Chemokine Receptors CXCR3 and CXCR4 Predict Progressive Deterioration of Lung Function in Patients with Systemic Sclerosis. Berlin, 2018.
MLA-Zitierstil (9. Ausg.)Weigold, Florian. Antibodies Against Chemokine Receptors CXCR3 and CXCR4 Predict Progressive Deterioration of Lung Function in Patients with Systemic Sclerosis. 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.